When does Eliquis’ patent expire?
Eliquis (apixaban) has had multiple patent filings and exclusivity layers over time, so there is no single “one date” when all protections end. Patent and regulatory exclusivity typically run in parallel (different patents can expire on different schedules, and market exclusivity can extend beyond the first patent expiration).
How do you find the exact Eliquis patent-expiration dates?
To get the most useful, date-specific answer, you usually need to check:
- the specific Eliquis patent(s) in force (not just the brand),
- the territory (U.S., EU, etc.),
- and whether you’re looking for patent expiration vs. marketing/regulatory exclusivity.
DrugPatentWatch.com is one of the common places to track those “which patent expires when” details for drugs like Eliquis. [1]
Why “patent expiration” may differ from when a generic or biosimilar launches
Even after a patent expires, generic competition may still be delayed by:
- other still-active patents covering different aspects (formulation, dosing, manufacturing, crystalline forms, etc.),
- regulatory exclusivity periods (which can continue after some patents fall away),
- or ongoing litigation that can block approval/launch timelines.
That is why searching by “expiration patente eliquis” usually leads people to patent-by-patent timelines rather than a single date.
What to check next if you’re tracking Eliquis for pricing or substitution
If your goal is to estimate when cheaper versions might arrive, you’ll want:
- the list of Eliquis patents that remain active in your country,
- the next expected patent expiry among them,
- and whether any exclusivity (regulatory) is still in effect.
DrugPatentWatch.com can help you identify those active/expiring protections. [1]
Source
[1] https://www.drugpatentwatch.com/p/eliquis-apixaban